Replies to post #174523 on Innovation Pharmaceuticals Inc (IPIX)

[iclight]

Oncology products sponsored by a company (like K) from P1 have a 5% chance at getting to NDA.

https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf

And it's probably much smaller for those P1s that show no ORR. But that's where the discussion of biomarkers comes in.